De Rechter S, Breysem L, Mekahli D (2017) Is autosomal dominant polycystic kidney disease becoming a pediatric disorder? Front Pediatr 5:272. https://doi.org/10.3389/fped.2017.00272

Article  PubMed  PubMed Central  Google Scholar 

Gimpel C, Bergmann C, Bockenhauer D et al (2019) International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people. Nat Rev Nephrol 15:713–726. https://doi.org/10.1038/s41581-019-0155-2

Article  PubMed  PubMed Central  Google Scholar 

Helal I, Reed B, McFann K, Yan XD, Fick-Brosnahan GM, Cadnapaphornchai M, Schrier RW (2011) Glomerular hyperfiltration and renal progression in children with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 6:2439–2443. https://doi.org/10.2215/cjn.01010211

Article  PubMed  PubMed Central  Google Scholar 

Fick GM, Duley IT, Johnson AM, Strain JD, Manco-Johnson ML, Gabow PA (1994) The spectrum of autosomal dominant polycystic kidney disease in children. J Am Soc Nephrol 4:1654–1660. https://doi.org/10.1681/asn.v491654

Article  CAS  PubMed  Google Scholar 

Ho TA, Godefroid N, Gruzon D, Haymann JP, Maréchal C, Wang X, Serra A, Pirson Y, Devuyst O (2012) Autosomal dominant polycystic kidney disease is associated with central and nephrogenic defects in osmoregulation. Kidney Int 82:1121–1129. https://doi.org/10.1038/ki.2012.225

Article  CAS  PubMed  Google Scholar 

De Rechter S, Bockenhauer D, Guay-Woodford LM et al; for the ADPedKD Consortium (2019) ADPedKD: a global online platform on the management of children with ADPKD. Kidney Int Rep 4:1271–1284. https://doi.org/10.1016/j.ekir.2019.05.015

Marlais M, Cuthell O, Langan D, Dudley J, Sinha MD, Winyard PJ (2016) Hypertension in autosomal dominant polycystic kidney disease: a meta-analysis. Arch Dis Child 101:1142–1147. https://doi.org/10.1136/archdischild-2015-310221

Article  PubMed  Google Scholar 

Baker A, King D, Marsh J, Makin A, Carr A, Davis C, Kirby C (2015) Understanding the physical and emotional impact of early-stage ADPKD: experiences and perspectives of patients and physicians. Clin Kidney J 8:531–537. https://doi.org/10.1093/ckj/sfv060

Article  PubMed  PubMed Central  Google Scholar 

JYNARQUE (2020) US prescribing information. Otsuka Pharmaceutical Co., Ltd., Tokyo. https://www.otsuka-us.com/sites/g/files/qhldwo6171/files/media/static/JYNARQUE-PI.pdf. Accessed 4 Jun 2023

Schaefer F, Mekahli D, Emma F, Gilbert RD, Bockenhauer D, Cadnapaphornchai MA, Shi L, Dandurand A, Sikes K, Shoaf SE (2019) Tolvaptan use in children and adolescents with autosomal dominant polycystic kidney disease: rationale and design of a two-part, randomized, double-blind, placebo-controlled trial. Eur J Pediatr 178:1013–1021. https://doi.org/10.1007/s00431-019-03384-x

Article  PubMed  PubMed Central  Google Scholar 

Mekahli D, Guay-Woodford L, Cadnapaphornchai MA, Greenbaum LA, Litwin M, Seeman T, Dandurand A, Shi L, Sikes K, Shoaf SE, Schaefer F (2023) Tolvaptan for children and adolescents with autosomal dominant polycystic kidney disease: randomized controlled trial. Clin J Am Soc Nephrol 18:36–46. https://doi.org/10.2215/CJN.0000000000000022

Article  PubMed  Google Scholar 

Gimpel C, Bergmann C, Mekahli D (2022) The wind of change in the management of autosomal dominant polycystic kidney disease in childhood. Pediatr Nephrol 37:473–487. https://doi.org/10.1007/s00467-021-04974-4

Article  PubMed  Google Scholar 

Irazabal MV, Rangel LJ, Bergstralh EJ et al; CRISP Investigators (2015) Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials. J Am Soc Nephrol 26:160–172.https://doi.org/10.1681/asn.2013101138

Cornec-Le Gall E, Audrézet MP, Rousseau A et al (2016) The PROPKD score: a new algorithm to predict renal survival in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 27:942–951. https://doi.org/10.1681/asn.2015010016

Article  PubMed  Google Scholar 

Cornec-Le Gall E, Audrézet MP, Chen JM et al (2013) Type of PKD1 mutation influences renal outcome in ADPKD. J Am Soc Nephrol 24:1006–1013. https://doi.org/10.1681/asn.2012070650

Article  PubMed  PubMed Central  Google Scholar 

Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637. https://doi.org/10.1681/asn.2008030287

Article  PubMed  PubMed Central  Google Scholar 

Breysem L, De Keyzer F, Schellekens P, Dachy A, De Rechter S, Janssens P, Vennekens R, Bammens B, Irazabal MV, Van Ongeval C, Harris PC, Mekahli D; CRISP Consortium (2023) Risk severity model for pediatric autosomal dominant polycystic kidney disease using 3D ultrasound volumetry. Clin J Am Soc Nephrol 18:581–591.https://doi.org/10.2215/cjn.0000000000000122

Nowak KL, You Z, Gitomer B, Brosnahan G, Torres VE, Chapman AB, Perrone RD, Steinman TI, Abebe KZ, Rahbari-Oskoui FF, Yu ASL, Harris PC, Bae KT, Hogan M, Miskulin D, Chonchol M (2018) Overweight and obesity Are predictors of progression in early autosomal dominant polycystic kidney disease. J Am Soc Nephrol 29:571–578. https://doi.org/10.1681/asn.2017070819

Article  CAS  PubMed  Google Scholar 

Zheng D, Wolfe M, Cowley BD Jr, Wallace DP, Yamaguchi T, Grantham JJ (2003) Urinary excretion of monocyte chemoattractant protein-1 in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 14:2588–2595. https://doi.org/10.1097/01.asn.0000088720.61783.19

Article  CAS  PubMed  Google Scholar 

Messchendorp AL, Meijer E, Visser FW, Engels GE, Kappert P, Losekoot M, Peters DJM, Gansevoort RT; on behalf of the DIPAK-1 study investigators (2019) Rapid progression of autosomal dominant polycystic kidney disease: urinary biomarkers as predictors. Am J Nephrol 50:375-385. https://doi.org/10.1159/000502999

Azukaitis K, Ju W, Kirchner M et al; ESCAPE Trial Group (2019) Low levels of urinary epidermal growth factor predict chronic kidney disease progression in children. Kidney Int 96:214–221. https://doi.org/10.1016/j.kint.2019.01.035

Dachy A, Van Loo L, Mekahli D (2023) Autosomal dominant polycystic kidney disease in children and adolescents: assessing and managing risk of progression. Adv Kidney Dis Health 30:236–244. https://doi.org/10.1053/j.akdh.2023.01.007

Article  PubMed  Google Scholar 

Mekahli D, Woolf AS, Bockenhauer D (2010) Similar renal outcomes in children with ADPKD diagnosed by screening or presenting with symptoms. Pediatr Nephrol 25:2275–2282. https://doi.org/10.1007/s00467-010-1617-8

Article  PubMed  Google Scholar 

Selistre L, de Souza V, Ranchin B, Hadj-Aissa A, Cochat P, Dubourg L (2012) Early renal abnormalities in children with postnatally diagnosed autosomal dominant polycystic kidney disease. Pediatr Nephrol 27:1589–1593. https://doi.org/10.1007/s00467-012-2192-y

Article  PubMed  Google Scholar 

Wong H, Vivian L, Weiler G, Filler G (2004) Patients with autosomal dominant polycystic kidney disease hyperfiltrate early in their disease. Am J Kidney Dis 43:624–628. https://doi.org/10.1053/j.ajkd.2003.12.026

Article  PubMed  Google Scholar 

Gabow PA, Johnson AM, Kaehny WD, Kimberling WJ, Lezotte DC, Duley IT, Jones RH (1992) Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int 41:1311–1319. https://doi.org/10.1038/ki.1992.195

Article  CAS  PubMed  Google Scholar 

Fick-Brosnahan GM, Tran ZV, Johnson AM, Strain JD, Gabow PA (2001) Progression of autosomal-dominant polycystic kidney disease in children. Kidney Int 59:1654–1662. https://doi.org/10.1046/j.1523-1755.2001.0590051654.x

Article  CAS  PubMed  Google Scholar 

Cadnapaphornchai MA, Masoumi A, Strain JD, McFann K, Schrier RW (2011) Magnetic resonance imaging of kidney and cyst volume in children with ADPKD. Clin J Am Soc Nephrol 6:369–376. https://doi.org/10.2215/cjn.03780410

Article  PubMed  PubMed Central  Google Scholar 

Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter JL (1995) Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med 123:754–762. https://doi.org/10.7326/0003-4819-123-10-199511150-00003

Article  CAS  PubMed  Google Scholar 

Ruggenenti P, Perna A, Mosconi L, Matalone M, Pisoni R, Gaspari F, Remuzzi G (1997) Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies. The “Gruppo Italiano di Studi Epidemiologici in Nefrologia” (GISEN). Kidney Int Suppl 63:S54–S57

CAS  PubMed  Google Scholar 

Gansevoort RT, Meijer E, Chapman AB, Czerwiec FS, Devuyst O, Grantham JJ, Higashihara E, Krasa HB, Ouyang J, Perrone RD, Torres VE; TEMPO 3:4 Investigators, (2016) Albuminuria and tolvaptan in autosomal-dominant polycystic kidney disease: results of the TEMPO 3:4 Trial. Nephrol Dial Transplant 31:1887–1894. https://doi.org/10.1093/ndt/gfv422

Dicks E, Ravani P, Langman D, Davidson WS, Pei Y, Parfrey PS (2006) Incident renal events and risk factors in autosomal dominant polycystic kidney disease: a population and family-based cohort followed for 22 years. Clin J Am Soc Nephrol 1:710–717. https://doi.org/10.2215/cjn.01581105

Article  PubMed  Google Scholar 

Fencl F, Janda J, Bláhová K, Hríbal Z, Stekrová J, Puchmajerová A, Seeman T (2009) Genotype-phenotype correlation in children with autosomal dominant polycystic kidney disease. Pediatr Nephrol 24:983–989. https://doi.org/10.1007/s00467-008-1090-9

Article  PubMed  Google Scholar 

Ranganathan P, Pramesh CS, Aggarwal R (2017) Common pitfalls in statistical analysis: measures of agreement. Perspect Clin Res 8:187–191. https://doi.org/10.4103/picr.picr_123_17

Article  PubMed  PubMed Central  Google Scholar 

Grantham JJ, Torres VE (2016) The importance of total kidney volume in evaluating progression of polycystic kidney disease. Nat Rev Nephrol 12:667–677. https://doi.org/10.1038/nrneph.2016.135

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chebib FT, Torres VE (2021) Assessing risk of rapid progression in autosomal dominant polycystic kidney disease and special considerations for disease-modifying therapy. Am J Kidney Dis 78:282–292. https://doi.org/10.1038/nrneph.2016.135

Article  CAS  PubMed  Google Scholar 

Jdiaa SS, Husainat NM, Mansour R, Kalot MA, McGreal K, Chebib FT, Perrone RD, Yu A, Mustafa RA (2022) A systematic review of reported outcomes in ADPKD studies. Kidney Int Rep 7:1964–1979. https://doi.org/10.1016/j.ekir.2022.06.012

Article  PubMed  PubMed Central  Google Scholar 

Mekahli D, Womack H, Dahl NK (2022) Perspectives on drug development in early ADPKD. Clin J Am Soc Nephrol 17:1555–1558. https://doi.org/10.2215/cjn.05190422